Filter search criteria using below inputs
Click on magnifying glass icon to search
Company | Country | Symbol |
---|
Time | Volume | MRNA |
---|---|---|
09:32 ET | 64325 | 70.5 |
09:34 ET | 16788 | 70.3255 |
09:36 ET | 20819 | 70.4133 |
09:38 ET | 31733 | 70.55 |
09:39 ET | 15860 | 70.335 |
09:41 ET | 10390 | 69.955 |
09:43 ET | 15503 | 69.905 |
09:45 ET | 23215 | 70.115 |
09:48 ET | 9114 | 70.16 |
09:50 ET | 17228 | 70.48 |
09:52 ET | 15031 | 70.4494 |
09:54 ET | 9497 | 70.749 |
09:56 ET | 18586 | 70.78 |
09:57 ET | 14368 | 70.3 |
09:59 ET | 10814 | 70.165 |
10:01 ET | 9745 | 70.44 |
10:03 ET | 16689 | 70.6 |
10:06 ET | 28562 | 70.875 |
10:08 ET | 28646 | 70.8 |
10:10 ET | 59417 | 71.11 |
10:12 ET | 31920 | 71.215 |
10:14 ET | 35876 | 71.04 |
10:15 ET | 30335 | 71.29 |
10:17 ET | 19072 | 71.245 |
10:19 ET | 11960 | 71.25 |
10:21 ET | 10897 | 71.29 |
10:24 ET | 16062 | 71.07 |
10:26 ET | 21120 | 71.265 |
10:28 ET | 17812 | 71.285 |
10:30 ET | 19576 | 71.36 |
10:32 ET | 22863 | 71.53 |
10:33 ET | 67305 | 71.69 |
10:35 ET | 21524 | 71.8 |
10:37 ET | 15152 | 71.8863 |
10:39 ET | 50215 | 71.9 |
10:42 ET | 68548 | 72.065 |
10:44 ET | 18550 | 71.965 |
10:46 ET | 13899 | 72.02 |
10:48 ET | 24740 | 72.345 |
10:50 ET | 18869 | 72.35 |
10:51 ET | 17044 | 72.435 |
10:53 ET | 18623 | 72.41 |
10:55 ET | 35702 | 72.38 |
10:57 ET | 19156 | 72.29 |
11:00 ET | 19668 | 72.055 |
11:02 ET | 18486 | 72.2057 |
11:04 ET | 39455 | 72.665 |
11:06 ET | 39557 | 72.585 |
11:08 ET | 75230 | 73.07 |
11:09 ET | 70538 | 73.175 |
11:11 ET | 31894 | 73.105 |
11:13 ET | 28773 | 73.315 |
11:15 ET | 52527 | 73.39 |
11:18 ET | 54333 | 73.63 |
11:20 ET | 57329 | 73.8562 |
11:22 ET | 29527 | 73.685 |
11:24 ET | 36176 | 74.03 |
11:26 ET | 32811 | 74 |
11:27 ET | 52036 | 73.825 |
11:29 ET | 47185 | 73.9 |
11:31 ET | 63008 | 74.185 |
11:33 ET | 68730 | 74.39 |
11:36 ET | 53703 | 74.52 |
11:38 ET | 42570 | 74.23 |
11:40 ET | 26762 | 74.0841 |
11:42 ET | 24752 | 73.99 |
11:44 ET | 50359 | 74.455 |
11:45 ET | 78955 | 74.8 |
11:47 ET | 52718 | 74.87 |
11:49 ET | 62260 | 74.92 |
11:51 ET | 35540 | 74.935 |
11:54 ET | 51581 | 75.14 |
11:56 ET | 86397 | 74.97 |
11:58 ET | 55318 | 74.34 |
12:00 ET | 57738 | 74.46 |
12:02 ET | 23561 | 74.11 |
12:03 ET | 35424 | 74.01 |
12:05 ET | 37690 | 74 |
12:07 ET | 23668 | 74.06 |
12:09 ET | 25015 | 74.3295 |
12:12 ET | 26249 | 74.14 |
12:14 ET | 42388 | 74.4 |
12:16 ET | 10614 | 74.33 |
12:18 ET | 43447 | 73.89 |
12:20 ET | 32717 | 73.7732 |
12:21 ET | 20935 | 73.78 |
12:23 ET | 33948 | 73.73 |
12:25 ET | 25167 | 73.445 |
12:27 ET | 27488 | 73.305 |
12:30 ET | 32759 | 73.5 |
12:32 ET | 17061 | 73.205 |
12:34 ET | 48372 | 73.435 |
12:36 ET | 22941 | 73.17 |
12:38 ET | 25587 | 73.2599 |
12:39 ET | 16585 | 73.385 |
12:41 ET | 19387 | 73.3 |
12:43 ET | 11766 | 73.27 |
12:45 ET | 23471 | 73.19 |
12:48 ET | 7295 | 73.12 |
12:50 ET | 37436 | 72.8 |
12:52 ET | 44997 | 72.67 |
12:54 ET | 15289 | 72.89 |
12:56 ET | 13067 | 72.91 |
12:57 ET | 17241 | 73.235 |
12:59 ET | 16305 | 73.05 |
01:01 ET | 11329 | 72.96 |
01:03 ET | 6744 | 72.96 |
01:06 ET | 5514 | 72.845 |
01:08 ET | 8142 | 72.955 |
01:10 ET | 10224 | 72.9 |
01:12 ET | 11327 | 72.79 |
01:14 ET | 7965 | 72.68 |
01:15 ET | 8887 | 72.7931 |
01:17 ET | 9105 | 72.695 |
01:19 ET | 9541 | 72.735 |
01:21 ET | 9212 | 72.81 |
01:24 ET | 10375 | 72.92 |
01:26 ET | 21720 | 73.1765 |
01:28 ET | 13709 | 73.15 |
01:30 ET | 10430 | 73.15 |
01:32 ET | 11648 | 73.2057 |
01:33 ET | 11163 | 73.02 |
Company sortable | Market Cap sortable | P/E Ratio (TTM) sortable | EPS Growth (5yr) sortable |
---|---|---|---|
Moderna Inc | 26.6B | -4.7x | --- |
ICON PLC | 24.5B | 34.5x | +4.68% |
Biontech SE | 29.4B | -53.4x | --- |
Biogen Inc | 29.1B | 24.9x | -18.14% |
Grifols SA | 7.2B | 36.4x | --- |
Charles River Laboratories International Inc | 10.5B | 24.6x | +15.57% |
Moderna, Inc. is a biotechnology company. The Company is advancing a new class of medicines made of messenger ribonucleic acid (mRNA). It is developing therapeutics and vaccines for infectious diseases, immuno-oncology, rare diseases and autoimmune diseases, independently and with its strategic collaborators. mRNA medicines are designed to direct the body’s cells to produce intracellular, membrane or secreted proteins that have a therapeutic or preventive benefit with the potential to address a spectrum of diseases. Its diverse development pipeline consists of 45 therapeutic and vaccine programs, nine of which are in late-stage development. Its products include COVID-19 vaccines (mRNA-1273/Spikevax, next-generation mRNA-1283), RSV vaccine (mRNA-1345), Seasonal influenza vaccines (mRNA-1010, mRNA-1011, mRNA-1012, mRNA-1020 and mRNA-1030), Combination vaccines (mRNA-1083, mRNA-1230, mRNA-1045 and mRNA-1365), CMV vaccine (mRNA-1647), EBV vaccine (mRNA-1189 and mRNA-1195) and others.
Our Ratings feature offers company-specific research ratings from providers such as First Call, S&P and Argus.
Open a New Account, or Login if you're a client.
You have access to a comprehensive selection of independent research reports from providers such as TD Securities, S&P, INK, and Argus.
Open a New Account, or Login if you're a client.
Market Cap | $26.6B |
---|---|
Revenue (TTM) | $5.1B |
Shares Outstanding | 384.4M |
Dividend Yield | 0.00% |
Annual Dividend Rate | --- |
Ex-Dividend Date | 01-01-01 |
Pay Date | 01-01-01 |
Beta | 1.68 |
EPS | $-15.37 |
Book Value | $36.27 |
P/E Ratio | -4.7x |
Price/Sales (TTM) | 5.3 |
Price/Cash Flow (TTM) | --- |
Operating Margin | -91.78% |
Our Calendar feature allows you to view a wide selection of market and company events, including earnings, dividends, splits, rating changes, guidance, and more. Access past, current and future events in WebBroker.
Open a New Account, or Login if you're a client.